InterCure Ltd.
NASDAQ:INCR · NASDAQ Global Market
+$0.08 today
Vol 0.02M · Avg 0.04M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-36.00%
Period High
$1.73
Period Low
$0.73
Latest
$0.96
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Edap Tms S.a.
EDAP
$178.23M
Unicycive Therapeutics, Inc.
NASDAQ:UNCY
$153.02M
Assertio Holdings, Inc.
NASDAQ:ASRT
$151.86M
American Well Corporation
NYSE:AMWL
$145.20M
Cardiol Therapeutics Inc.
NASDAQ:CRDL
$121.04M
Repare Therapeutics Inc.
RPTX
$114.24M
Fortress Biotech, Inc.
NASDAQ:FBIO
$95.01M
CAMP4 Therapeutics Corporation
NASDAQ:CAMP
$84.11M
MindWalk Holdings Corp.
NASDAQ:HYFT
$72.87M
Biomea Fusion, Inc.
NASDAQ:BMEA
$71.40M
What is the latest INCR filing?
The latest filing shown is 6-K dated Jun 15, 2026.
How many recent filings does INCR have?
Intrinsic Alpha currently shows 20 recent filings for INCR.
Explore More
Continue the stock analysis
Jump to another research area for this company.